Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes

Pankaj Ranjan Karn, Wonkyung Cho, Sung Joo Hwang

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Since the pioneering research of Bangham et al. in 1965, liposomes have attracted a large amount of interest as potential carriers of various bioactive molecules for clinical applications. However, scaling-up conventional methods of liposome preparation has been proven to be challenging. Compared with conventional methods, processes that use supercritical fluid (SCF)-CO 2 require a reduced amount of organic solvent, are relatively fast and simple to perform, and yield stable and more uniform liposomes. A number of studies have demonstrated that SCF-CO2 methods might be suitable for industrial-scale manufacturing of liposomes. In this review there are two topics being discussed. We provide an overview of liposomal drug products and aim to describe the physicochemical properties of liposomes prepared using various SCF methods. We review all of the available literature on SCF-CO2-based liposomes and focus on the future applications of these innovative technologies in industrial-scale liposome preparation.

Original languageEnglish
Pages (from-to)1529-1548
Number of pages20
JournalNanomedicine
Volume8
Issue number9
DOIs
Publication statusPublished - 2013 Sep

Fingerprint

Supercritical fluids
Liposomes
Drug products
drug
fluid
Pharmaceutical Preparations
physicochemical property
scaling
manufacturing
Carbon Monoxide
method
product
Organic solvents
Technology
Molecules
Research

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

@article{c2e9ed3d702d422f8b114eae3148d481,
title = "Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes",
abstract = "Since the pioneering research of Bangham et al. in 1965, liposomes have attracted a large amount of interest as potential carriers of various bioactive molecules for clinical applications. However, scaling-up conventional methods of liposome preparation has been proven to be challenging. Compared with conventional methods, processes that use supercritical fluid (SCF)-CO 2 require a reduced amount of organic solvent, are relatively fast and simple to perform, and yield stable and more uniform liposomes. A number of studies have demonstrated that SCF-CO2 methods might be suitable for industrial-scale manufacturing of liposomes. In this review there are two topics being discussed. We provide an overview of liposomal drug products and aim to describe the physicochemical properties of liposomes prepared using various SCF methods. We review all of the available literature on SCF-CO2-based liposomes and focus on the future applications of these innovative technologies in industrial-scale liposome preparation.",
author = "Karn, {Pankaj Ranjan} and Wonkyung Cho and Hwang, {Sung Joo}",
year = "2013",
month = "9",
doi = "10.2217/nnm.13.131",
language = "English",
volume = "8",
pages = "1529--1548",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "9",

}

Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes. / Karn, Pankaj Ranjan; Cho, Wonkyung; Hwang, Sung Joo.

In: Nanomedicine, Vol. 8, No. 9, 09.2013, p. 1529-1548.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes

AU - Karn, Pankaj Ranjan

AU - Cho, Wonkyung

AU - Hwang, Sung Joo

PY - 2013/9

Y1 - 2013/9

N2 - Since the pioneering research of Bangham et al. in 1965, liposomes have attracted a large amount of interest as potential carriers of various bioactive molecules for clinical applications. However, scaling-up conventional methods of liposome preparation has been proven to be challenging. Compared with conventional methods, processes that use supercritical fluid (SCF)-CO 2 require a reduced amount of organic solvent, are relatively fast and simple to perform, and yield stable and more uniform liposomes. A number of studies have demonstrated that SCF-CO2 methods might be suitable for industrial-scale manufacturing of liposomes. In this review there are two topics being discussed. We provide an overview of liposomal drug products and aim to describe the physicochemical properties of liposomes prepared using various SCF methods. We review all of the available literature on SCF-CO2-based liposomes and focus on the future applications of these innovative technologies in industrial-scale liposome preparation.

AB - Since the pioneering research of Bangham et al. in 1965, liposomes have attracted a large amount of interest as potential carriers of various bioactive molecules for clinical applications. However, scaling-up conventional methods of liposome preparation has been proven to be challenging. Compared with conventional methods, processes that use supercritical fluid (SCF)-CO 2 require a reduced amount of organic solvent, are relatively fast and simple to perform, and yield stable and more uniform liposomes. A number of studies have demonstrated that SCF-CO2 methods might be suitable for industrial-scale manufacturing of liposomes. In this review there are two topics being discussed. We provide an overview of liposomal drug products and aim to describe the physicochemical properties of liposomes prepared using various SCF methods. We review all of the available literature on SCF-CO2-based liposomes and focus on the future applications of these innovative technologies in industrial-scale liposome preparation.

UR - http://www.scopus.com/inward/record.url?scp=84893161274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893161274&partnerID=8YFLogxK

U2 - 10.2217/nnm.13.131

DO - 10.2217/nnm.13.131

M3 - Review article

C2 - 23987112

AN - SCOPUS:84893161274

VL - 8

SP - 1529

EP - 1548

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 9

ER -